Investing Profile

Matthew Foy

Photo of Matthew Foy, Partner at SR One

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Oxford Network
96 CONNECTIONS
London Business School Network
66 CONNECTIONS
UCL Network
26 CONNECTIONS
cb
SR One Partner
3
CompanyStageDateRound SizeTotal Raised
Fore Biotherapeutics
Series DAug 2023$75M
$130M
Co-investors: Michal Silverberg (Novartis Venture Fund), Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Ran Nussbaum (Pontifax Venture Capital)
Akamis Bio
Series CMay 2015$39M
Series BJul 2012$34M
$110M
Co-investors: Maina Bhaman (Soffinova Partners), Robert Nelsen (ARCH Venture Partners)
Fund raising The Grange Festival2015 - Present
Founder OneStart2012 - Present
Partner SROne2011 - Present
Fund Raising The Royal Ballet School2011 - Present
Consultant Longbow Capital LLP2010 - 2011
Vice President - M&A Banker / Private Equity Greenhill & Co.2002 - 2010
UCL Drug Discovery
London Business School Entrepreneurship & Strategy
University of Oxford BSc & MSc Biological Sciences - Cell and Molecular Biology